1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Novartis Gene Therapies Investigator-Initiated Trials (IITs), Research Collaborations and Consortia is sponsored by Novartis Gene Therapies. Novartis Gene Therapies supports investigator-initiated trials (IIT), research collaborations and consortia that provide valuable information regarding the safety, efficacy, pharmacology, and tolerability of products.
They provide grants exclusively in their therapeutic areas of expertise (rare and life-threatening neurological genetic diseases) and based on the scientific merit of the investigator's proposal.
Get alerted about grants like this
Save a search for “Novartis Gene Therapies” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Qualified researchers and institutions proposing investigator-initiated trials, research collaborations, or consortia in Novartis Gene Therapies' therapeutic areas of expertise. Confirm the full requirements in the official notice before applying.
Novartis Gene Therapies Investigator-Initiated Trials (IITs), Research Collaborations and Consortia is funded by Novartis Gene Therapies. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Investigator-Initiated Trials (IITs), Research Collaborations and Consortia is sponsored by Novartis Gene Therapies. Novartis Gene Therapies supports investigator-initiated trials (IIT), research collaborations, and consortia that contribute valuable information regarding the safety, efficacy, pharmacology, and tolerability of products in rare and life-threatening neurological genetic diseases. Grants are based on the scientific merit of the proposal.
Novartis Gene Therapies Request for Funding is sponsored by Novartis Gene Therapies. Novartis Gene Therapies supports investigator-initiated trials (IITs), research collaborations, and consortia within their therapeutic areas of expertise (rare and life-threatening neurological genetic diseases). This research can provide valuable information regarding the safety, efficacy, pharmacology, and tolerability of products and supplement comprehensive data generated in registration studies.